Skip to main content
Fig. 7 | Immunity & Ageing

Fig. 7

From: B-1 derived anti-Thy-1 B cells in old aged mice develop lymphoma/leukemia with high expression of CD11b and Hamp2 that different from TCL1 transgenic mice

Fig. 7

TC+Tg B1 B cells in neonate to early age are changed than TC–. Old aged TC–ATA B cells similar to human CLL/U-CLL and further some different. A Summary. In B-1 B cell generations, aged ability for lymphoma or CLL/lymphoma [13, 25, 178, 180], and V1-55 in C57BL/6 mice is high at 2-3 wk, than 1 wk [170]. Down: 2 mo Lin28 Tg+ changed are high V1-55 and decreased V1-55 with negative TdTKO Lin28 Tg+ persentage, as TdT requaded for B-2 from Pro-B (TdT+) move to Pre-B. When V1-55 and V12-3 B-1 Pro-B to Pre-B cell stage with heavy chain with surrogate light chain (SLC) association to B-2 analysis. Thus, increased in TC+Tg. B 12 mo microarray relative miRNA level Let-7 showed slightly higher in TC+Tg ATA B cells than TC–, and TC– ATA B are low miR150 and miR181b. C High increased CD11b and Hamp2 in old age TC– ATAμκTg mice. D Concludion of difference of TC+Tg and TC– mice to generated lymphoma/leukemia, and in C.B17 mice TC–ATAμκTg ATA B from neonate, middle age, and old aged. Old age ATAB lymphoma/leukemia generation with most similar to human TC+CLL/U–CLL and different to CLL with CD11b++Hamp2++, CD22++, CD24lo/–. CD23–CD49dlow are the some generated cancers. AGcA generate MZ B and changed to increased macrophages++ with intestine/colon tumor in old age

Back to article page